• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部患者的调强放疗:容积调强弧形放疗与容积旋转调强放疗的差异

ART for head and neck patients: On the difference between VMAT and IMPT.

作者信息

Góra Joanna, Kuess Peter, Stock Markus, Andrzejewski Piotr, Knäusl Barbara, Paskeviciute Brigita, Altorjai Gabriela, Georg Dietmar

机构信息

a Department of Radiation Oncology , Medical University of Vienna/AKH Wien , Vienna , Austria.

出版信息

Acta Oncol. 2015;54(8):1166-74. doi: 10.3109/0284186X.2015.1028590. Epub 2015 Apr 8.

DOI:10.3109/0284186X.2015.1028590
PMID:25850583
Abstract

UNLABELLED

Anatomical changes in the head-and-neck (H&N) region during the course of treatment can cause deteriorated dose distributions. Different replanning strategies were investigated for volumetric modulated arc therapy (VMAT) and intensity-modulated proton therapy (IMPT).

MATERIAL AND METHODS

For six H&N patients two repeated computed tomography (CT) and magnetic resonance (MR) (CT1/MR1 at week 2 and CT2/MR2 at week 4) scans were acquired additionally to the initial planning CT/MR. Organs-at-risk (OARs) and three targets (CTV70Gy, CTV63Gy, CTV56Gy) were delineated on MRs and transferred to respective CT data set. Simultaneously integrated boost plans were created using VMAT (two arcs) and IMPT (four beams). To assess the need of replanning the initial VMAT and IMPT plans were recalculated on repeated CTs. Furthermore, VMAT and IMPT plans were replanned on the repeated CTs. A Demon algorithm was used for deformable registration of the repeated CTs with the initial CT and utilized for dose accumulation. Total dose estimations were performed to compare ART versus standard treatment strategies.

RESULTS

Dosimetric evaluation of recalculated plans on CT1 and CT2 showed increasing OAR doses for both, VMAT and IMPT. The target coverage of recalculated VMAT plans was considered acceptable in three cases, while for all IMPT plans it dropped. Adaptation of the treatment reduced D2% for brainstem by 6.7 Gy for VMAT and by 8 Gy for IMPT, for particular patients. These D2% reductions were reaching 9 Gy and 14 Gy for the spinal cord. ART improved target dose homogeneity, especially for protons, i.e. D2% decreased by up to 8 Gy while D98% increased by 1.2 Gy.

CONCLUSION

ART showed benefits for both modalities. However, as IMPT is more conformal, the magnitude of dosimetric changes was more pronounced compared to VMAT. Large anatomic variations had a severe impact on treatment plan quality for both VMAT and IMPT. ART is justified in those cases irrespective of treatment modalities.

摘要

未标注

头颈部(H&N)区域在治疗过程中的解剖学变化会导致剂量分布恶化。针对容积调强弧形放疗(VMAT)和调强质子治疗(IMPT)研究了不同的重新计划策略。

材料与方法

对于6名头颈部患者,除了初始计划的CT/MR扫描外,还额外获取了两次重复的计算机断层扫描(CT)和磁共振成像(MR)扫描(第2周的CT1/MR1和第4周的CT2/MR2)。在MR图像上勾画出危及器官(OARs)和三个靶区(CTV70Gy、CTV63Gy、CTV56Gy),并将其转移到各自的CT数据集。使用VMAT(两个弧形)和IMPT(四束射束)创建同步整合加量计划。为了评估重新计划的必要性,在重复的CT图像上重新计算初始VMAT和IMPT计划。此外,在重复的CT图像上对VMAT和IMPT计划进行重新计划。使用Demon算法对重复的CT图像与初始CT图像进行可变形配准,并用于剂量累积。进行总剂量估计以比较自适应放疗(ART)与标准治疗策略。

结果

对CT1和CT2上重新计算的计划进行剂量学评估显示,VMAT和IMPT的OAR剂量均增加。重新计算的VMAT计划的靶区覆盖在3例中被认为是可接受的,而所有IMPT计划的靶区覆盖均下降。对于特定患者,治疗调整使VMAT的脑干D2%降低了6.7 Gy,IMPT降低了8 Gy。脊髓的这些D2%降低分别达到9 Gy和14 Gy。ART改善了靶区剂量均匀性,尤其是对于质子,即D2%降低了多达8 Gy,而D98%增加了1.2 Gy。

结论

ART对两种治疗方式均显示出益处。然而,由于IMPT的适形性更好,与VMAT相比,剂量学变化的幅度更为明显。大的解剖学变异对VMAT和IMPT的治疗计划质量都有严重影响。在这些情况下,无论治疗方式如何,ART都是合理的。

相似文献

1
ART for head and neck patients: On the difference between VMAT and IMPT.头颈部患者的调强放疗:容积调强弧形放疗与容积旋转调强放疗的差异
Acta Oncol. 2015;54(8):1166-74. doi: 10.3109/0284186X.2015.1028590. Epub 2015 Apr 8.
2
Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.前列腺病例的调强质子治疗(IMPT)、容积旋转调强放疗(VMAT)和4π放疗的治疗计划比较
Radiat Oncol. 2017 Jan 11;12(1):10. doi: 10.1186/s13014-016-0761-0.
3
Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.使用锥形束CT图像对头颈部肿瘤进行自动质子治疗计划调整的可行性。
Radiat Oncol. 2016 Apr 30;11:64. doi: 10.1186/s13014-016-0641-7.
4
Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.网格大小对XiO脑癌治疗计划系统中均匀扫描和调强质子治疗计划的影响。
J Appl Clin Med Phys. 2015 Sep 8;16(5):447–456. doi: 10.1120/jacmp.v16i5.5510.
5
Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes.晚期头颈癌患者在治疗过程中发生变化导致的潜在质子和光子剂量降低。
J Appl Clin Med Phys. 2017 Nov;18(6):104-113. doi: 10.1002/acm2.12189. Epub 2017 Sep 18.
6
Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.局部晚期非小细胞肺癌患者的小光斑强度调制质子治疗和容积调制弧形治疗:一项剂量学比较研究。
J Appl Clin Med Phys. 2018 Nov;19(6):140-148. doi: 10.1002/acm2.12459. Epub 2018 Oct 17.
7
Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.点扫描质子弧形治疗可降低口咽癌患者的毒性。
Med Phys. 2023 Mar;50(3):1305-1317. doi: 10.1002/mp.16098. Epub 2023 Jan 17.
8
Is there room for combined modality treatments? Dosimetric comparison of boost strategies for advanced head and neck and prostate cancer.是否有联合治疗的空间?头颈部和前列腺癌的推量策略的剂量学比较。
J Radiat Res. 2013 Jul;54 Suppl 1(Suppl 1):i97-112. doi: 10.1093/jrr/rrt067.
9
Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Intensity-Modulated Proton Therapy for Angiosarcoma of the Scalp.螺旋断层放疗、容积旋转调强放疗和强度调制质子治疗头皮血管肉瘤的剂量学比较。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820985866. doi: 10.1177/1533033820985866.
10
Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.头颈部癌中,点扫描质子治疗与容积调强弧形光子治疗在危及器官保护和计划稳健性方面的比较。
Med Phys. 2015 Nov;42(11):6589-98. doi: 10.1118/1.4933245.

引用本文的文献

1
Cone beam CT-based adaptive intensity modulated proton therapy assessment using automated planning for head-and-neck cancer.基于锥形束 CT 的自适应强度调制质子治疗对头颈癌的自动计划评估。
Radiat Oncol. 2024 Jan 23;19(1):13. doi: 10.1186/s13014-024-02406-9.
2
Daily Head and Neck Treatment Assessment for Optimal Proton Therapy Planning Robustness.每日进行头颈部治疗评估以优化质子治疗计划的稳健性。
Cancers (Basel). 2023 Jul 22;15(14):3719. doi: 10.3390/cancers15143719.
3
Large anatomical changes in head-and-neck cancers - A dosimetric comparison of online and offline adaptive proton therapy.
头颈部癌症的巨大解剖学变化——在线与离线自适应质子治疗的剂量学比较
Clin Transl Radiat Oncol. 2023 Mar 31;40:100625. doi: 10.1016/j.ctro.2023.100625. eCollection 2023 May.
4
Proton Therapy in Head and Neck Cancer Treatment: State of the Problem and Development Prospects (Review).质子治疗在头颈部癌症治疗中的应用:问题现状与发展前景(综述)。
Sovrem Tekhnologii Med. 2021;13(4):70-80. doi: 10.17691/stm2021.13.4.08. Epub 2021 Aug 28.
5
Trend analysis of the dosimetric impact of anatomical changes during proton therapy for maxillary sinus carcinoma.上颌窦癌质子治疗中解剖变化的剂量学影响的趋势分析。
J Appl Clin Med Phys. 2021 Sep;22(9):298-306. doi: 10.1002/acm2.13391. Epub 2021 Aug 17.
6
Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation.头颈部解剖结构变化的强度调制质子治疗:稳健优化与在线自适应的比较。
Radiother Oncol. 2021 Jun;159:39-47. doi: 10.1016/j.radonc.2021.03.008. Epub 2021 Mar 17.
7
Comparison of weekly and daily online adaptation for head and neck intensity-modulated proton therapy.每周和每日在线自适应对头颈部强度调制质子治疗的比较。
Phys Med Biol. 2021 Feb 25;66(5). doi: 10.1088/1361-6560/abe050.
8
Potential benefits of adaptive intensity-modulated proton therapy in nasopharyngeal carcinomas.自适应调强质子治疗鼻咽癌的潜在获益。
J Appl Clin Med Phys. 2021 Jan;22(1):174-183. doi: 10.1002/acm2.13128. Epub 2020 Dec 18.
9
Roadmap: proton therapy physics and biology.质子治疗物理与生物学路线图
Phys Med Biol. 2021 Feb 26;66(5). doi: 10.1088/1361-6560/abcd16.
10
Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results.质子铅笔束扫描放疗治疗鼻咽癌:剂量学参数和 2 年结果。
Eur Arch Otorhinolaryngol. 2021 Mar;278(3):763-769. doi: 10.1007/s00405-020-06175-5. Epub 2020 Jul 4.